TAILIEUCHUNG - INTERIM REPORT: Nokia Corporation Q3 2012 Interim Report

Whilst we are cautious about making firm conclusions about the similarities and differences of countries from the pilot data because of the different questions used in some cases, we have employed a statistically conservative approach to analysing across the countries in order to look for general patterns. We have used an approach that looks at the average scores for each country, and then groups the countries according to whether or not their results are significantly different. This approach does not in any way correct for the variation in questions asked, but on the assumption that they are largely equivalent, it. | NOKIA INTERIM REPORT 1 36 Nokia Corporation October 18 2012 at 13 00 CET 1 Nokia Corporation Q3 2012 Interim Report FINANCIAL AND OPERATING HIGHLIGHTS Nokia Group non-IFRS EPS in Q3 2012 of EUR reported EPS EUR - Nokia Group achieves operating profitability on an underlying basis with Q3 non-IFRS operating margin of . - Nokia Siemens Networks non-IFRS operating margin significantly improved quarter-on-quarter and year-on-year to in Q3 company executing well on restructuring and strategy that focuses on key markets and product segments. - Devices Services Q3 non-IFRS operating margin improved quarter-on-quarter to negative . - Nokia Group ended Q3 with gross cash of EUR billion and net cash of EUR billion. - Nokia Group Q3 net cash from operating activities of negative EUR 429 million including cash outflows related to restructuring activities of approximately EUR 390 million. Nokia Group net sales in Q3 2012 were EUR billion down from EUR billion in Q2 2012 - Nokia Siemens Networks net sales increased quarter-on-quarter and year-on-year to EUR billion. - Lumia Q3 volumes decreased quarter-on-quarter to million units as we shared the exciting innovation ahead with our new line of Lumia products. - Mobile Phones Q3 volumes increased quarter-on-quarter to 77 million units strong sales start for new Asha full touch smartphones with volumes of million units. Commenting on the Q3 results Stephen Elop Nokia CEO said As we expected Q3 was a difficult quarter in our Devices Services business however we are pleased that we shifted Nokia Group to operating profitability on a non-IFRS basis. In Q3 we continued to manage through a tough transitional quarter for our smart devices business as we shared the exciting innovation ahead with our new line of Lumia products. In our mobile phones business the positive consumer response to our new Asha full touch smartphones translated into strong sales. And in Q3 our mobile phones .

• Tài chính doanh nghiệp
• Therapeutic Potential
• Principles and Application
• Thyroid Cancer Research
• Evaluation and Management
• Pediatric Thyroid Nodules
• Papillary Thyroid
• Medicinal plant
• Human health
• Today’s context
• Herbal products especially
• Bioactive compounds
• Medicinal plants
• Plant waste
• Biological activity
• Therapeutic potential of plant waste
• Endothelial progenitor cells
• Neuronal damage
• Rat model of epilepsy
• Role of autophagy
• Antimicrobial peptides
• Fish disease
• Therapeutic alternative
• Hyalophora cecropia
• BMC Cancer
• Breast cancer
• Triple negative breast cancer
• Gene expression
• Therapeutic target
• N cadherin
• Haematological malignancies
• Tumour phenotype
• Cell adhesion molecule N cadherin
• Anaplastic large cell lymphoma
• Anaplastic lymphoma kinase
• Therapeutic significance
• Cytokine independent
• Genome Biology
• Cancer therapy
• Long non coding RNAs
• Transcript attractive
• Potential therapeutic
• Cancer treatments
• Gastric cancer
• Cancer associated fibroblasts
• Extracellular matrix
• Tumor microenvironment
• Prognostic biomarkers
• Therapeutic targets
• Early diagnosis
• Circulating anti filamin C autoantibody
• Potential serum biomarker
• Adequate therapeutic intervention
• BMC Chemistry
• Pyrimidine derivatives
• Anti inflammatory
• Heterocyclic compounds
• Therapeutic agents
• Livestock production
• Stem cells
• Therapeutic applications
• Stem cells in livestock production
• Potential applications
• Intrahepatic cholangiocarcinoma
• Hub genes
• Gene expression profiling
• Malignant tumor
• trình bày báo cáo
• tài liệu báo cáo khoa học
• báo cáo y học
• kiến thức y học
• nghiên cứu y học
• báo cáo khoa học
• công trình nghiên cứu về y học
• tài liệu về y học
• cách trình bày báo cáo
• Worldwide Trends
• Infectious Disease
• Research Revealed
• Report medicine
• traditional medicine
• scientific reports
• immune system
• Antimicrobial
• biosynthesis
• Báo cáo sinh học hay
• báo cáo sinh học
• công trình nghiên cứu sinh học
• tài liệu về sinh học